Lactulose Abc Laxative Syrup 180ml

Therapeutic indications

Short-term treatment of occasional constipation

Dosage

1 tablespoon = 15 ml = 10 g of lactulose 1 teaspoon = 5 ml = 3.3 g of lactulose The lactulose solution can be administered diluted or as it is together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. Take preferably in the evening. Adults : the recommended dose is 15 ml per day. Children : the recommended dose is on average 10 ml per day. Infants : the recommended dose is on average 5 ml per day. Do not exceed the recommended dose. The correct dose is the minimum sufficient to produce easy evacuation of soft stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.

Overdose

Symptoms Excessive doses can cause abdominal pain and diarrhea, resulting in fluid and electrolyte losses must be replaced. See also the information in section 4.4 “Special warnings and precautions for use” regarding the abuse of laxatives. Treatment Interruption of treatment or dose reduction. The resulting loss of fluids and electrolytes must be replaced.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Laxatives are contraindicated in subjects with acute abdominal pain or of unknown origin, nausea, vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects with galactosemia. Generally contraindicated during pregnancy and lactation (see section 4.6). Generally contraindicated in pediatric age (see section 4.4).

Side effects

Occasionally: isolated cramping pains or abdominal colic, more frequent in cases of severe constipation and flatulence during the first days of treatment which normally disappears after a few days. Gastrointestinal disorders Flatulence, abdominal pain, nausea and vomiting; diarrhea (with excessive doses) Investigations Electrolyte imbalance due to diarrhea

Pregnancy and breastfeeding

There are no adequate and well-controlled studies on the use of the drug in pregnancy or breastfeeding. Therefore, the medicine should only be used in case of need, under the direct supervision of the doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant.

Special warnings

Warnings. In patients presenting with disorders caused by excessive intestinal meteorism it is advisable to start treatment with the minimum doses indicated; these doses can be gradually increased in relation to the patient's response. If constipation is stubborn, see a doctor. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In severe cases, the onset of dehydration or hypokalaemia (decrease in potassium in the blood) is possible, which can cause cardiac or neuromuscular dysfunctions, especially in the case of simultaneous treatment with cardiac glucosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (and, therefore, the possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Precautions for use In children under 12 years of age, the medicine can only be used after consulting your doctor. It should be taken into account that the reflex to evacuate may be altered during treatment. The treatment of chronic or recurrent constipation always requires the intervention of the doctor for the diagnosis, the prescription of drugs and the surveillance during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) lasting more than two weeks or when the use of the laxative fails to produce effects. Patients on digitalis therapy should consult their physician before starting therapy. Lactulose is absorbed to a very small extent and has no caloric value. However, LACTULOSE ABC contains, in addition to lactulose, also galactose, lactose and small quantities of other sugars. This must be taken into account in the treatment of diabetic patients and in patients on low calorie diets. For diabetic patients it is necessary to consult the doctor. It is also advisable that elderly people or those in poor health conditions consult their doctor before using the medicine. Lactulose should be administered with caution in lactose intolerant patients. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

Expiry and Retention

This medicine does not require any special storage conditions.

Active principles

180 ml bottle of syrup 100 ml of syrup contain: Active ingredient: Lactulose g 66.7 For the full list of excipients see section 6.1

Excipients

Syrup: Sodium benzoate, Purified water